NYSE: $JNJ A Breakthrough for Patients In a significant milestone for hematology and immunology, the FDA has officially approved Imaavy (nipocalimab-aahu). This approval marks a historical turning point as it is the first-ever treatment specifically indicated for adults with warm autoimmune hemolytic anemia (wAIHA). Understanding Warm Autoimmune Hemolytic Anemia (wAIHA) Warm autoimmune hemolytic anemia is…